Long-term efficacy and safety of TNF-alpha-inhibitor infliximab in severe atopic dermatitis

被引：3
|
作者：
Jacobi, A [1 ]
Schuler, G [1 ]
Hertl, M [1 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Dermatol, D-8520 Erlangen, Germany
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2004年 / 50卷 / 03期
关键词：
D O I：
10.1016/j.jaad.2003.10.016
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P10
引用
收藏
页码：P3 / P3
页数：1
相关论文
共 50 条
  • [21] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
    Jang, Dong Hyek
    Heo, Seok Jae
    Kook, Hyung Don
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Yeon
    Ahn, Jiyoung
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Long-term application of extracorporeal photochemotherapy in severe atopic dermatitis
    Prinz, B
    Michelsen, S
    Pfeiffer, C
    Plewig, G
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (04) : 577 - 582
  • [23] Long-term tralokinumab therapy in moderate to severe atopic dermatitis
    Lorenz, Judith
    AKTUELLE DERMATOLOGIE, 2023, 49 (03) : 91 - 91
  • [24] Long-term efficacy and safety of dupilumab in adolescents with severe atopic dermatitis: a 3-year real-life study
    Chiei-Gallo, Alessandra
    Barei, Francesca
    Calzari, Paolo
    Pisapia, Armando
    Marzano, Angelo V.
    Ferrucci, Silvia M.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [25] Long-term safety and efficacy of infliximab for the treatment of ankylosing spondylitis
    Elalouf, Ofir
    Elkayam, Ori
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1719 - 1726
  • [26] Long-term efficacy and safety of infliximab treatment of ankylosing spondylitis
    Boeger, CA
    Wittwer, H
    Schattenkirchner, M
    Kellner, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 64 - 64
  • [27] EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE
    Fries, W.
    Privitera, A. C.
    Lo Presti, M. A.
    Mastronardi, M.
    Cappello, M.
    Grossi, L.
    Lauria, A.
    Principi, M.
    Della Valle, N.
    Buccianti, N.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S134 - S134
  • [28] Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil
    Benez, A
    Fierlbeck, G
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (03) : 638 - 639
  • [29] Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study
    Jo, Christine E.
    Georgakopoulos, Jorge R.
    Ladda, Matthew
    Ighani, Arvin
    Mufti, Asfandyar
    Drucker, Aaron M.
    Piguet, Vincent
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1530 - 1532
  • [30] Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China
    Wang, Yuyi
    Jia, Ruiling
    Hu, Qin
    Tao, Xiao
    He, Qi
    Luo, Guangying
    Xiong, Qiong
    Zhang, Zhongyu
    Xiao, Yujuan
    Liu, Yi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
12345